Influenza Antiviral Reduces Infection Rate

Article

CHICAGO-Researchers at the Interscience Conference on Antimicrobial Agents and Chemotherpay (ICAAC) reported a new influenza medication limits the spread of the infectious disease within households.

The Family Influenza Transmission (FIT) study was presented at the conference, showing that simultaneous treatment of the person initially infected, along with prophylaxis treatment of other household members, protected those not infected in 63% of households. Tamiflu, known as oseltamivir phosphate generically, has shown to reduce flu-like symptoms and reduce the ability of the virus to infect others.

Tamiflu is a Roche Laboratory product.

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content